Author:
Linnemann Birgit,Prochnow Stephanie,Mani Helen,Schwonberg Jan,Lindhoff-Last Edelgard
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference32 articles.
1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR on behalf of the TASC II Working Group (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33:S1–S75. doi: 10.1016/j.ejvs.2006.09.024
2. Clagett GP, Sobel M, Jackson MR, Lip GYH, Angelder M, Verhaeghe R (2004) Antithrombotic therapy in peripheral arterial occlusive disease. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:609S–626S. doi: 10.1378/chest.126.3_suppl.609S
3. Antithrombotic Trialist’s Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71–86. doi: 10.1136/bmj.324.7336.S71
4. Goldhaber SZ, Manson JE, Stampfer MJ, LaMotte F, Rosner B, Buring JE, Hennekens CH (1992) Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians’ Health Study. Lancet 340:143–145. doi: 10.1016/0140-6736(92)93216-A
5. Alexander JH, Harrington RA, Tuttle RH, Berdan LD, Linchoff AM, Deckers JW, Simoons ML, Guerci A, Hochman JS, Wilcox RG, Kitt MM, Eisenberg PR, Califf RM, Topol EJ, Karsh K, Ruzyllo W, Stepinska J, Widimsky P, Boland JB, Armstrong PW (1999) Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol 83:1147–1151. doi: 10.1016/S0002-9149(99)00049-1